CEOCFO Magazine Interview

Dr. Myla Lai-Goldman was recently interviewed by CEOCFO Magazine about the GeneCentric technology known as the Lung Subtype Platform. The October 15th issue covers the importance of subtype determination in lung cancer and how the GeneCentric LSP-TM test can fulfill an unmet medical need.

Download PDF of Entire Article